Home › Funds › Ranmore Fund Management Ltd › XRAY

Ranmore Fund Management Ltd position in XRAY

DENTSPLY SIRONA INC · Health Care

Ranmore Fund Management Ltd reported holding 2,800,000 shares of XRAY (DENTSPLY SIRONA INC) in its Q3 2026 13F filing — a position valued at US$24.8M, representing 2.75% of its reported portfolio and ranking #19 among its reported holdings. Ranmore Fund Management Ltd has disclosed XRAY holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)2.80M sh
Reported value held$24.81M
Portfolio Weight2.75%
First reportedQ2 2026
Last changeAdd
Updated2026-10-20

Last updated: 2026-10-20 · Source: SEC EDGAR Form 13F-HR

How Ranmore Fund Management Ltd's XRAY position evolved

Ranmore Fund Management Ltd first disclosed a stake in XRAY in Q2 2026 at 2,600,000 shares (US$27.6M). Across 2 filings, Ranmore Fund Management Ltd increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,800,000 shares valued at US$24.8M — an increase of 200,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 2.60M $27.59M New
Q3 2026 2.80M $24.81M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About XRAY and 13F data

XRAY (DENTSPLY SIRONA INC) is a Health Care company. 13 other funds we track also report a position in XRAY — the largest reported positions include ARIEL INVESTMENTS, LLC (US$85.2M), Southpoint Capital Advisors LP (US$74.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding XRAY

All XRAY fund holders →

FAQ

How long has Ranmore Fund Management Ltd held XRAY?

Ranmore Fund Management Ltd has disclosed XRAY holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Ranmore Fund Management Ltd's current position in XRAY?

As of Q3 2026, Ranmore Fund Management Ltd holds 2.80M shares of XRAY (DENTSPLY SIRONA INC), valued at $24.81M, representing 2.75% of its reported portfolio and ranking #19.

Has Ranmore Fund Management Ltd been buying or selling XRAY?

In the latest 13F filing (Q3 2026), Ranmore Fund Management Ltd increased its position in XRAY.

Which other funds hold XRAY?

Other major institutional holders of XRAY include ARIEL INVESTMENTS, LLC, Southpoint Capital Advisors LP, among 13 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.